▲ 0.77%
prev close
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Congressional Trades
8
All tracked trades
Members Trading
6
Unique members
Net Activity
+4
6 buys · 2 sells
Members Who Traded This Stock
8 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2025-12-08 | AZNAstraZeneca PLC - American Depositary Shares | Buy | $1,001 - $15,000 | 190d ago | — | |
| 2025-11-19 | AZNAstraZeneca PLC - American Depositary Shares | Buy | $1,001 - $15,000 | 219d ago | — | |
| 2025-10-30 | AZNAstraZeneca PLC - American Depositary Shares | Buy | $1,001 - $15,000 | 243d ago | — | |
| 2025-06-09 | AZNAstraZeneca PLC - American Depositary Shares | Buy | $1,001 - $15,000 | 343d ago | — | |
| 2025-04-21 | AZNAstraZeneca PLC - American Depositary Shares | Sell | $1,001 - $15,000 | 436d ago | — | |
| 2025-03-03 | AZNAstraZeneca PLC - American Depositary Shares | Buy | $1,001 - $15,000 | 462d ago | — | |
| 2024-10-29 | AZNAstraZeneca PLC - American Depositary Shares | Buy | $1,001 - $15,000 | 313d ago | — | |
| 2023-07-10 | AZNAstraZeneca PLC - American Depositary Shares | Sell | $100,001 - $250,000 | 1074d ago | — |
2025-12-08
Julia Letlow
AZN
Amount
$1,001 - $15,000
Filed
190d ago
2025-11-19
Gilbert Cisneros
AZN
Amount
$1,001 - $15,000
Filed
219d ago
2025-10-30
Lisa McClain
AZN
Amount
$1,001 - $15,000
Filed
243d ago
2025-06-09
Lisa McClain
AZN
Amount
$1,001 - $15,000
Filed
343d ago
2025-04-21
Bruce Westerman
AZN
Amount
$1,001 - $15,000
Filed
436d ago
2025-03-03
Bruce Westerman
AZN
Amount
$1,001 - $15,000
Filed
462d ago
2024-10-29
Valerie Hoyle
AZN
Amount
$1,001 - $15,000
Filed
313d ago
2023-07-10
Daniel Goldman
AZN
Amount
$100,001 - $250,000
Filed
1074d ago
Recent News
Powered by Polygon.io
PD-1 and PD-L1 Inhibitors Clinical Trial Pipeline Analysis Demonstrates 180+ Key Companies on the Horizon Expected to Transform the Oncology Space | DelveInsight
Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026 | Benchmark More Than 1,800 Biopharma Deals with Various Indexes
Bioinformatics Collaboration and Licensing Deals 2019-2026 | Compare Upfronts, Milestones, and Royalties for 1,230+ Deals
Autoimmune Disease Therapeutics Market Size to Reach USD 137.85 Billion by 2035 as Biologics and Precision Medicine Drive Growth | SNS Insider
Oral Obesity Therapies Market to Reach $6.32 Billion by 2030 as Demand for GLP-1 Treatments Accelerates
Trade Timeline
Congressional activity, newest first
Julia Letlow
2025-12-08 · Purchase
$1,001 - $15,000
Gilbert Cisneros
2025-11-19 · Purchase
$1,001 - $15,000
Lisa McClain
2025-10-30 · Purchase
$1,001 - $15,000
Lisa McClain
2025-06-09 · Purchase
$1,001 - $15,000
Bruce Westerman
2025-04-21 · Sale
$1,001 - $15,000
Bruce Westerman
2025-03-03 · Purchase
$1,001 - $15,000
Valerie Hoyle
2024-10-29 · Purchase
$1,001 - $15,000
Daniel Goldman
2023-07-10 · Sale
$100,001 - $250,000